Current imaging modalities in the diagnosis of cervical cancer

Gynecologic Oncology

Volumn 110, Issue 3 SUPPL.2, 2008, Pages

  Jiménez de la Peña, Mar ^a   Martínez de Vega Fernández, Vicente ^a   Recio Rodríguez, Manuel ^a   Carrascoso Arranz, Javier ^a   Herráiz Hidalgo, Luis ^a   Alvarez Moreno, Elena ^a  

^a HOSPITAL QUIRÓN   (Spain)

Author keywords

Cervical cancer; High resolution MRI; Local staging; Pelvic MRI

Indexed keywords

FLUORODEOXYGLUCOSE;

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; TRACHEA SURGERY; UTERINE CERVIX CANCER;

FEMALE; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; UTERINE CERVICAL NEOPLASMS;

EID: 50049112420     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.05.030     Document Type: Article

References (12)

1. Padhani A.R. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J. Magn. Reson. Imaging 16 (2002) 407-422
2. Padhani A.R. MRI for assessing antivascular cancer treatments. Br. J. Radiol. 76 suppl (2003) S60-s80
3. Padhani A.R., and Leach M.O. Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging. Abdom Imaging 30 (2005) 324-341
4. Subak L.L., Hrikak H., Powell C.B., Azizi L., and Stern J.L. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet. Gynecol. 86 (1995) 43-50
5. Sahdev A., Jones J., Shepherd J.H., and Reznek R.H. Post-surgical MR imaging appearances of the female pelvis following trachelectomy. Radiographics 25 (2005) 41-52
6. Narayan K., Mckenzie A.F., Hicks R.J., et al. Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy. Int. Gynecol. Cancer 13 (2003) 657-663
7. Sheperd J.H., Ngan H.Y., Neven P., Fryatt I., Woodhouse C.R., and Hendry W.F. Multivariate analysis of factors affecting survival in pelvic exenteration. Int. J. Gynecol. Cancer 4 (1994) 361-370
8. Rockall A.G., Ghosh S., Alexander-Sefre F., et al. Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA?. Gynecol. Oncol. 101 (2006) 244-249
9. Sironi S., Buda A., Picchio M., et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 238 (2006) 272-279
10. Rockall A.G., Sohaib S.A., Harisinghani M.G., et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J. Clin. Oncol. 23 (2005) 2813-2821
11. Fujii S., Matsusue E., Kanasaki Y., et al. Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur. Radiol. 18 (2008) 18-23
12. McVeigh P., Syed A., Milosevic M., Fyles A., and Haider M. DWI in cervical cancer. Eur. Radiol. 18 (2008) 1058-1064